EnPlusOne Biosciences
Latest round
- Seed
Last raised
- Dec 2024
Total raised
- $22M
Investors
- 3
About EnPlusOne Biosciences
Founded in 2022 by Daniel Wiegand (CEO), and Jonathan Rittichier (CSO), and based in Massachusetts, US, EnPlusOne Biosciences Inc. was formed as a technology spinout from the Wyss Institute for Biologically Inspired Engineering at Harvard University and operates as a biotechnology research company that develops an ezRNa platform, used for RNA synthesis. In September 2022, EnPlusOne Biosciences Inc. The company provides a patented ezRNA technology that incorporates a diverse array of nucleotide modifications for enzymatically building RNA as well as offers long-term manufacturing solutions to sustainably deliver RNA medicines at scale. The technology offers site-specific and diverse RNA alterations to aid in the commercialization of RNA oligonucleotides used in a variety of medicines.
Who invested in EnPlusOne Biosciences
3 investors across 2 rounds
See all investors in EnPlusOne Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EnPlusOne Biosciences
Who invested in EnPlusOne Biosciences?
EnPlusOne Biosciences has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EnPlusOne Biosciences raised?
EnPlusOne Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did EnPlusOne Biosciences last raise money?
EnPlusOne Biosciences's most recent round on record is a Seed, in Dec 2024.
What does EnPlusOne Biosciences do?
Founded in 2022 by Daniel Wiegand (CEO), and Jonathan Rittichier (CSO), and based in Massachusetts, US, EnPlusOne Biosciences Inc.
Where is EnPlusOne Biosciences headquartered?
EnPlusOne Biosciences is headquartered in Watertown, US.
Which VCs invest in companies like EnPlusOne Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at EnPlusOne Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like EnPlusOne Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.